Literature DB >> 31899233

Risk Factors for Infection after Prostate Biopsy in the United States.

Jonathan E Shoag1, Christopher Gaffney1, Morgan Pantuck1, Tianyi Sun2, Michael Gorin3, Edward Schaeffer4, Art Sedrakyan2, Andrew Vickers5, Jim Hu6.   

Abstract

METHODS: We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked data from 2001 to 2015 and recorded 30-day infection rates and emergency department, hospital and, intensive care unit (ICU) admissions. We performed adjusted analyses to analyze the effect of age, demographic data, surgeon volume, rectal swab use, and biopsy year on infections.
RESULTS: We found that the overall rate of postbiopsy infections increased from 2001 (5.9%) to 2007 (7.2%) but remained stable through 2015. Despite this, postbiopsy emergency room visits rose from 0.2% to 0.5% (95% confidence interval [CI] 0.2%-0.4%, P < .01), hospitalizations rose from 0.5% to 1.3% (95% CI 0.5%-1.0%, P < .01), and ICU admissions increased from 0.1% to 0.3% (95% CI 0.1%-0.3%, P < .01). Patients of surgeons who performed 25 biopsies per year had lower odds of postbiopsy infection (odds ratio 0.65; 95% CI 0.61-0.69) and a lower risk of hospitalization (odds ratio 0.50; 95% CI 0.43-0.59) as compared to patients of surgeons who performed one biopsy per year. Rectal swab use increased over the study period but remained low (1.8% in 2015).
CONCLUSION: While the overall rate of postbiopsy infections has stabilized since 2007, admissions to the emergency room, hospital, and ICU continue to rise. Increased surgeon volume was associated with a decreased risk of infection.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31899233      PMCID: PMC7549646          DOI: 10.1016/j.urology.2019.12.023

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  26 in total

Review 1.  Disseminated intravascular coagulation following transrectal ultrasound guided prostate biopsy.

Authors:  M F Al-Otaibi; W Al-Taweel; S Bin-Saleh; M Herba; A G Aprikian
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

2.  Antibiotic use and resistance--proving the obvious.

Authors:  John Turnidge; Keryn Christiansen
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

3.  Acute bacterial meningitis after transrectal needle biopsy of the prostate: a case report.

Authors:  H Erdogan; M N Ekinci; M B Hoscan; A Erdogan; H Arslan
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-03-04       Impact factor: 5.554

4.  Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies.

Authors:  Paul Toren; Roshan Razik; John Trachtenberg
Journal:  Can Urol Assoc J       Date:  2010-02       Impact factor: 1.862

5.  Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.

Authors:  Deepak Batura; G Gopal Rao; Peder Bo Nielsen
Journal:  BJU Int       Date:  2010-03-16       Impact factor: 5.588

6.  Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial.

Authors:  Paul F Pinsky; Howard L Parnes; Gerald Andriole
Journal:  BJU Int       Date:  2013-11-21       Impact factor: 5.588

7.  Targeted Antimicrobial Prophylaxis Does Not Always Prevent Sepsis after Transrectal Prostate Biopsy.

Authors:  Pengbo Jiang; Michael A Liss; Richard J Szabo
Journal:  J Urol       Date:  2018-03-21       Impact factor: 7.450

8.  Variation in Use of Prostate Biopsy Following Changes in Prostate Cancer Screening Guidelines.

Authors:  Mark A Henry; David H Howard; Benjamin J Davies; Christopher P Filson
Journal:  J Urol       Date:  2017-05-06       Impact factor: 7.450

9.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Authors:  Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

Review 10.  Complications After Systematic, Random, and Image-guided Prostate Biopsy.

Authors:  Marco Borghesi; Hashim Ahmed; Robert Nam; Edward Schaeffer; Riccardo Schiavina; Samir Taneja; Wolfgang Weidner; Stacy Loeb
Journal:  Eur Urol       Date:  2016-08-17       Impact factor: 20.096

View more
  3 in total

1.  Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution.

Authors:  Matthew J Roberts; Alastair Macdonald; Sachinka Ranasinghe; Harrison Bennett; Patrick E Teloken; Patrick Harris; David Paterson; Geoff Coughlin; Nigel Dunglison; Rachel Esler; Robert A Gardiner; Thomas Elliott; Louisa Gordon; John Yaxley
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-05       Impact factor: 5.554

2.  Development and validation of a nomogram based on multiparametric magnetic resonance imaging and elastography-derived data for the stratification of patients with prostate cancer.

Authors:  Zhimin Ding; Di Song; Huaiyu Wu; Hongtian Tian; Xiuqin Ye; Weiyu Liang; Jinfeng Xu; Fajin Dong
Journal:  Quant Imaging Med Surg       Date:  2021-07

3.  Construction and Comparison of Different Models in Detecting Prostate Cancer and Clinically Significant Prostate Cancer.

Authors:  Yongheng Zhou; Wenqiang Qi; Jianfeng Cui; Minglei Zhong; Guangda Lv; Sifeng Qu; Shouzhen Chen; Rongyang Li; Benkang Shi; Yaofeng Zhu
Journal:  Front Oncol       Date:  2022-07-12       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.